AI
| Followers | 2528 |
| Posts | 250766 |
| Boards Moderated | 33 |
| Alias Born | 05/06/2014 |
Sunday, September 10, 2017 12:38:52 PM
$PMCB PharmaCyte is laying the grounds for its clinical trials with pancreatic #cancer. PMCB
To that end, we have restructured our agreement with Austrianova to strengthen our partnership.
PharmaCyte CEO Kenneth Waggoner says, “We felt that securing the right of first refusal now was imperative as we move forward with our planned clinical trial in locally advanced pancreatic cancer.”
http://pharmacyte.com/pharmacyte-restructures-agreements-with-austrianova-to-strengthen-partnership/?utm_source=Facebook&utm_term=Sep+6+PR
To that end, we have restructured our agreement with Austrianova to strengthen our partnership.
PharmaCyte CEO Kenneth Waggoner says, “We felt that securing the right of first refusal now was imperative as we move forward with our planned clinical trial in locally advanced pancreatic cancer.”
http://pharmacyte.com/pharmacyte-restructures-agreements-with-austrianova-to-strengthen-partnership/?utm_source=Facebook&utm_term=Sep+6+PR
investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
